Major study reveals how medicare patients fare with leukemia treatments
NCT ID NCT07188428
Summary
This study analyzed Medicare claims data from 2,298 patients with chronic myeloid leukemia (CML) to understand how treatments work in real-world settings. Researchers examined treatment patterns, medication adherence, healthcare costs, and outcomes for patients receiving different types of targeted therapies. The goal was to learn how well current treatments perform outside of clinical trials and identify areas for improvement in patient care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA, CHRONIC MYELOID are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis
East Hanover, New Jersey, 07936, United States
Conditions
Explore the condition pages connected to this study.